Getty ImagesThe stock quoted a 52-week low price of Rs 1164.1 and a high of Rs 1974.95.
Earlier, shares of the company saw a gap down opening in the morning.
A total of 2,589 lakh shares changed hands on the counter till 10:20AM (IST).
The stock of Shriram Finance Ltd. commanded a market value of Rs 69357.92 crore, according to BSE.
The stock traded at a price-to-earning (P/E) multiple of 11.84, while the price-to-book value ratio stood at 1.08. Return on equity (ROE) was at 13.87 per cent, according to exchange data.
In the BSE500 pack, 349 stocks traded in the green, while 152 stocks were in the red.
The stock's beta value, which measures volatility in relation to the broader market, stood at 1.69.
Promotor/FII Holding
Promoters held 23.47 per cent in Shriram Finance Ltd. as of 30-Jun-2023 while foreign and domestic institutional investors owned 55.36 per cent and 8.84 per cent, respectively.
Moving averages
The 200-DMA of the stock stood at 1509.19 on October 06, while the 50-DMA was at 1872.78. If a stock trades below 50-DMA and 200-DMA, it usually means the immediate trend is upward. On the other hand, if the stock trades below 50-DMA and 200-DMA, it is considered as bearish trend and if trades between 50-DMA and 200-DMA, then it suggests the stock can go either way.
Friday, 06 Oct, 2023- Front Page
- Pure Politics
- Companies
- Economy
- Learn more about our print editionMore
India Inc may Log a Nifty Performance in Second QtrCompanies making up the Nifty 50 are expected to report another quarter of robust aggregate profit growth in the three months to September, helped by moderating commodity prices, a lower base effect, and standout performances by select automotive and financial businesses.
Colgate to Brush up on Science than Focus on AyurvedaColgate-Palmolive chairman and CEO Noel Wallace believes his company got distracted by Patanjali and said the company that controls half the oral care segment in the country will rather focus on its scientific credentials “and technical superiority and not in ayurveda”. In an interaction with ET’s Sagar Malviya & Bodhisatva Ganguli, Wallace also outlined his strategy in a country where more than half the rural population do not brush daily and 80% of consumers in cities brush just once a day.
Lose Weight Now, Ask Them HowOfficially, it’s not available in India. Yet, Ozempic, Mounjaro and Wegovy, the revolutionary new drugs for weight loss used by the likes of Tesla CEO Elon Musk and Hollywood stars, have become all the rage among the country’s swish set, too.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: Sensex Today Live, SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Get Unlimited Access to The Economic Times 
